论文部分内容阅读
巴西政府希望其国内生物技术市场在2000年时达到100亿美元,虽然拉丁美洲在过去的30年中对技术开发的总的投资仅为5亿美元,与发达国家的2000亿美元相比可说微乎其微。尽管巴西政府对生物技术采取了积极的态度,但由于缺乏财政资助而未有多大成就。早在80年代早期,巴西即实施了国家生物技术计划PRONAB,其后又发展成PADET生物技术计划。另外设在科学技术署的生物技术处的主要政策目标是促进公司、大学和研究中心间的合作。这种合作已产生了良好的结果,如位于里约热内卢大学的科学公园内已有三家主要
The Brazilian government hopes its domestic biotech market will reach 10 billion U.S. dollars by the year 2000. Although the total investment in technology development in Latin America in the past 30 years was only 500 million U.S. dollars, compared with 200 billion U.S. dollars in developed countries Little. Although the Brazilian government has taken a positive attitude towards biotechnology, it has not achieved much due to the lack of financial support. As early as the early 1980s, Brazil implemented PRONAB, a national biotechnology initiative, and later developed into the PADET biotechnology initiative. In addition, the main policy goal of the Biotechnology Division of the Department of Science and Technology is to promote cooperation among companies, universities and research centers. This cooperation has yielded good results, as there are already three major areas within the Science Park at the University of Rio de Janeiro